Search

Search Constraints

You searched for: Author/Creator Montero, Marta

Search Results

1. Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology. (September 2021)

2. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy. (1st March 2019)

3. Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study. Issue 24 (17th June 2022)

4. Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial. Issue 7 (July 2015)

5. Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial. Issue 7 (July 2015)

6. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study. Issue 8 (August 2020)

7. EGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. Issue 3 (2nd September 2021)

8. Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019. Issue 7 (17th January 2022)

9. Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection. Issue 2 (22nd June 2017)

10. Factors associated with the number of drugs in darunavir/cobicistat regimens. (5th October 2019)